Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Court Rules In Favor Of Medtronic In Fidelis Litigation

Medtronic, Inc. (Medtronic) reported that, the US District Court for the District of Minnesota dismissed with prejudice the master consolidated complaint for individuals and the master consolidated complaint for third-party payors relating to the multi-district litigation (MDL) involving Medtronic’s Sprint Fidelis defibrillator leads on grounds of federal preemption.

The Court issued a companion order that each case in the MDL will be dismissed with prejudice unless an individual plaintiff can establish his or her case survives the Court’s preemption analysis based on claims different from those asserted in the master complaints.

“We are pleased with the Court’s decision, which is consistent with the United States Supreme Court’s ruling in Riegel v. Medtronic last year, following a long line of circuit court decisions,” said Bill Hawkins, Medtronic’s chairman and chief executive officer. “This decision supports the principle that the U.S. Food and Drug Administration is the appropriate body to determine the safety and efficacy of innovative technologies.”